Effects of topical prostaglandin drops on angiogenesis in an in ovo chick chorioallantoic membrane model

References

• Harada C, Kimura A, Guo X, et al. Recent advances in genetically modified animal models of glaucoma and their roles in drug repositioning. Br J Ophthalmol 2019;103:161–166.
   PubMed Web of Science ®Google Scholar
• Khatib TZ, Martin KR. Neuroprotection in Glaucoma: towards clinical trials and precision medicine. Curr Eye Res 2020;45:327–338.
   PubMed Web of Science ®Google Scholar
• Fajgenbaum M, Ansari E. Prescribing trends in a glaucoma clinic and adherence to EGS guidelines: a retrospective, non-interventional, single-center UK study. Adv Ther 2017;34:2033–2042.
   PubMed Web of Science ®Google Scholar
• Mishra D, Sinha BP, Kumar MS. Comparing the efficacy of latanoprost (0.005%), bimatoprost (0.03%), travoprost (0.004%), and timolol (0.5%) in the treatment of primary open angle glaucoma. Korean J Ophthalmol 2014;28:399–407.
   PubMedGoogle Scholar
• Kammer JA, Katzman B, Ackerman SL, Hollander DA. Efficacy and tolerability of bimatoprost versus travoprost in patients previously on latanoprost: a 3-month, randomised, masked-evaluator, multicentre study. Br J Ophthalmol 2010;94:74–79.
   PubMed Web of Science ®Google Scholar
• Li T, Lindsley K, Rouse B, et al. Comparative effectiveness of first-line medications for primary open-angle glaucoma: a systematic review and network meta-analysis. Ophthalmology 2016;123:129–140.
   PubMed Web of Science ®Google Scholar
• Angeli A, Supuran CT. Prostaglandin receptor agonists as antiglaucoma agents (a patent review 2013–2018). Expert Opin Ther Pat 2019;29:793–803.
   PubMed Web of Science ®Google Scholar
• Tang W, Zhang F, Liu K, Duan X. Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: a meta-analysis. Medicine. 2019;98:e16597.
   PubMed Web of Science ®Google Scholar
• Kim E. o, Kim YH, Kang SH, et al. In vitro effects of preservative-free and preserved prostaglandin analogs on primary cultured human conjunctival fibroblast cells. Korean J Ophthalmol 2013;27:446–453.
   PubMedGoogle Scholar
• Di Staso S, Agnifili L, Cecannecchia S, et al. In vivo analysis of prostaglandins-induced ocular surface and periocular adnexa modifications in patients with glaucoma. In Vivo. 2018;32:211–220.
   PubMed Web of Science ®Google Scholar
• Pisella PJ, Debbasch C, Hamard P, et al. Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study. Invest Ophthalmol Vis Sci 2004;45:1360–1368.
   PubMed Web of Science ®Google Scholar
• Ciolofan A, Creţu OM, Mogoantă SŞ, Ciucă EM. The tyrosine kinase inhibitors effects on metastatic tumor graft in the chick chorioallantoic membrane assay. Rom J Morphol Embryol 2017;58:1257–1262.
   PubMed Web of Science ®Google Scholar
• Pacini S, Punzi T, Gulisano M, Ruggiero M. Friend erythroleukemia cells induce angiogenesis in chick embryo chorioallantoic membrane and in human umbilical vein endothelial cells. Biol Res 2008;41:109–117.
   PubMed Web of Science ®Google Scholar
• Comşa Ş, Popescu R, Avram Ş, et al. Bevacizumab modulation of the interaction between the MCF-7 cell line and the chick embryo chorioallantoic membrane. In Vivo 2017;31:199–203.
   PubMed Web of Science ®Google Scholar
• Matthews GBP, Persaud TVN. Influence of prostaglandin F2α on the development of the chick embryo: morphological and biochemical aspects. Experimentelle Pathologie 1976;12:100–108.
   Google Scholar
• Zijlstra A, Lewis DJ. Visualization and quantification of De Novo angiogenesis in ex ovo chicken embryos. In: Zudaire, E, Cuttitta, F (eds) The textbook of angiogenesis and lymphangiogenesis: methods and applications. Dordrecht: Springer; 2012: pp. 217–240.
   Google Scholar
• Harland DR, Lorenz LD, Fay K, et al. Acute effects of prostaglandin E1 and E2 on vascular reactivity and blood flow in situ in the chick chorioallantoic membrane. Prostaglandins Leukot Essent Fatty Acids 2012;87:79–89.
   PubMed Web of Science ®Google Scholar
• Ribatti D. Chicken chorioallantoic membrane angiogenesis model. Methods Mol Biol 2012;843:47–57.
   PubMedGoogle Scholar
• Blacher S, Devy L, Hlushchuk R, et al. Quantification of angiogenesis in the chicken chorioallantoic membrane (CAM). Image Anal Stereol 2011;23:169.
   Google Scholar
• Nowak-Sliwinska P, Segura T, Iruela-Arispe ML. The chicken chorioallantoic membrane model in biology, medicine and bioengineering. Angiogenesis 2014;17:779–804.
   PubMed Web of Science ®Google Scholar
• Inoue K, Shiokawa M, Higa R, et al. Adverse periocular reactions to five types of prostaglandin analogs. Eye 2012;26:1465–1472.
   PubMed Web of Science ®Google Scholar
• Klimko PG, Sharif NA. Discovery, characterization and clinical utility of prostaglandin agonists for the treatment of glaucoma. Br J Pharmacol 2019;176:1051–1058.
   PubMed Web of Science ®Google Scholar
• Lopes JF, Hubatsch DA, Amaris P. Effect of benzalkonium chloride-free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study Glaucoma. BMC Ophthalmol 2015;15:166.
   PubMed Web of Science ®Google Scholar
• Jha AK, Sarkar R, Udayan UK, et al. Bimatoprost in Dermatology. Indian Dermatol Online J 2018;9:224–228.
   PubMedGoogle Scholar
• Zalman Y, Klipper E, Farberov S, et al. Regulation of angiogenesis-related prostaglandin f2alpha-induced genes in the bovine corpus luteum1. Biol Reprod 2012;86:92.
   PubMed Web of Science ®Google Scholar
• Rakhila H, Bergeron M, Daris M, et al. Angiogenic activity of PGF2A in women with endometriosis. Fertil Steril 2015;104:e160.
   Web of Science ®Google Scholar
• Kaczynski P, Goryszewska E, Baryla M, Waclawik A. Prostaglandin F2α stimulates angiogenesis at the embryo-maternal interface during early pregnancy in the pig. Theriogenology 2020;142:169–176.
   PubMed Web of Science ®Google Scholar
• Sales KJ, List T, Boddy SC, et al. A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas. Cancer Res 2005;65:7707–7716.
   PubMed Web of Science ®Google Scholar
• DuBiner H, Cooke D, Dirks M, et al. Efficacy and safety of bimatoprost in patients with elevated intraocular pressure. Surv Ophthalmol 2001;45:S353–S360.
   PubMed Web of Science ®Google Scholar
• Gandolfi S, Simmons ST, Sturm R, et al. Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension. Adv Therapy 2001;18:110–121.
   PubMed Web of Science ®Google Scholar
• Holmstrom S, Buchholz P, Walt J, et al. Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma. Curr Med Res Opin 2005;21:1875–1883.
   PubMed Web of Science ®Google Scholar